These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 10225476

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Troglitazone improves GLUT4 expression in adipose tissue in an animal model of obese type 2 diabetes mellitus.
    Furuta M, Yano Y, Gabazza EC, Araki-Sasaki R, Tanaka T, Katsuki A, Hori Y, Nakatani K, Sumida Y, Adachi Y.
    Diabetes Res Clin Pract; 2002 Jun; 56(3):159-71. PubMed ID: 11947963
    [Abstract] [Full Text] [Related]

  • 3. Troglitazone stimulates pancreatic growth in congenitally CCK-A receptor-deficient OLETF rats.
    Jia DM, Fukumitsu KI, Tabaru A, Akiyama T, Otsuki M.
    Am J Physiol Regul Integr Comp Physiol; 2001 May; 280(5):R1332-40. PubMed ID: 11294751
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Troglitazone improves blood flow by inhibiting neointimal formation after balloon injury in Otsuka Long-Evans Tokushima fatty rats.
    Min KM, Park SW, Cho KY, Song MS, Kim DK, Park GS, Lee MK.
    Metabolism; 2002 Aug; 51(8):998-1002. PubMed ID: 12145772
    [Abstract] [Full Text] [Related]

  • 6. Troglitazone prevents fatty changes of the liver in obese diabetic rats.
    Jia DM, Tabaru A, Akiyama T, Abe S, Otsuki M.
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1183-91. PubMed ID: 11106100
    [Abstract] [Full Text] [Related]

  • 7. Troglitazone ameliorates abnormal activity of protein tyrosine phosphatase in adipose tissues of Otsuka Long-Evans Tokushima Fatty rats.
    Tagami S, Honda T, Yoshimura H, Homma H, Ohno K, Ide H, Sakaue S, Kawakami Y.
    Tohoku J Exp Med; 2002 Jul; 197(3):169-81. PubMed ID: 12365558
    [Abstract] [Full Text] [Related]

  • 8. Troglitazone prevents and reverses dyslipidemia, insulin secretory defects, and histologic abnormalities in a rat model of naturally occurring obese diabetes.
    Jia DM, Tabaru A, Nakamura H, Fukumitsu KI, Akiyama T, Otsuki M.
    Metabolism; 2000 Sep; 49(9):1167-75. PubMed ID: 11016899
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Troglitazone: a review of its use in the management of type 2 diabetes mellitus.
    Plosker GL, Faulds D.
    Drugs; 1999 Mar; 57(3):409-38. PubMed ID: 10193691
    [Abstract] [Full Text] [Related]

  • 12. Effects of troglitazone on collagen accumulation and distensibility of aortic wall in prestage of non-insulin-dependent diabetes mellitus of Otsuka Long-Evans Tokushima Fatty rats.
    Mizushige K, Noma T, Yao L, Yu Y, Kiyomoto H, Hosomi N, Fukui T, Kimura S, Abe Y, Matsuo H.
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):150-5. PubMed ID: 10630746
    [Abstract] [Full Text] [Related]

  • 13. Beneficial effect of troglitazone, an insulin-sensitizing antidiabetic agent, on coronary circulation in patients with non-insulin-dependent diabetes mellitus.
    Sekiya M, Suzuki J, Watanabe K, Funada J, Otani T, Akutsu H.
    Jpn Circ J; 2001 Jun; 65(6):487-90. PubMed ID: 11407727
    [Abstract] [Full Text] [Related]

  • 14. Metformin decreases blood pressure and obesity in OLETF rats via improvement of insulin resistance.
    Kosegawa I, Katayama S, Kikuchi C, Kashiwabara H, Negishi K, Ishii J, Inukai K, Oka Y.
    Hypertens Res; 1996 Mar; 19(1):37-41. PubMed ID: 8829822
    [Abstract] [Full Text] [Related]

  • 15. Troglitazone improves endothelial function and augments renal klotho mRNA expression in Otsuka Long-Evans Tokushima Fatty (OLETF) rats with multiple atherogenic risk factors.
    Yamagishi T, Saito Y, Nakamura T, Takeda S, Kanai H, Sumino H, Kuro-o M, Nabeshima Y, Kurabayashi M, Nagai R.
    Hypertens Res; 2001 Nov; 24(6):705-9. PubMed ID: 11768731
    [Abstract] [Full Text] [Related]

  • 16. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
    Yu JG, Kruszynska YT, Mulford MI, Olefsky JM.
    Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431
    [Abstract] [Full Text] [Related]

  • 17. Troglitazone stimulates pancreatic growth in normal rats.
    Jia DM, Otsuki M.
    Pancreas; 2002 Apr; 24(3):303-12. PubMed ID: 11893940
    [Abstract] [Full Text] [Related]

  • 18. Beneficial insulin-sensitizing and vascular effects of S15261 in the insulin-resistant JCR:LA-cp rat.
    Russell JC, Ravel D, Pégorier JP, Delrat P, Jochemsen R, O'Brien SF, Kelly SE, Davidge ST, Brindley DN.
    J Pharmacol Exp Ther; 2000 Nov; 295(2):753-60. PubMed ID: 11046115
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.